T1	Competing_trial 0 45	The patient is participating in another study
T2	Non-query-able 47 115	The patient is in an exclusion period determined by a previous study
T3	Informed_consent 117 182	The patient or his/her representative refuses to sign the consent
T4	Post-eligibility 184 258	It is impossible to correctly inform the patient or his/her representative
T5	Pregnancy_considerations 260 300	The patient is pregnant or breastfeeding
T6	Condition 320 336	contraindication
T7	Non-representable 302 409	The patient has a contraindication (or an incompatible drug association) for a treatment used in this study
T8	Device 429 443	coronary stent
T9	Temporal 448 467	less than 12 months
R1	Has_temporal Arg1:T8 Arg2:T9	
T10	Drug 583 590	aspirin
T11	Condition 591 598	allergy
R2	AND Arg1:T11 Arg2:T10	
T12	Observation 605 618	bleeding risk
T13	Qualifier 600 604	High
R3	Has_qualifier Arg1:T12 Arg2:T13	
T14	Measurement 628 637	platelets
T15	Value 638 651	<50,000 / mm3
T16	Measurement 670 672	Hb
T17	Value 673 684	<8.5 g / dL
T18	Condition 697 720	intracranial hemorrhage
T19	Condition 724 741	subdural hematoma
T20	Procedure 743 757	major surgery,
T21	Procedure 758 782	parenchymal organ biopsy
T22	Condition 793 799	trauma
T23	Qualifier 786 792	severe
R4	Has_qualifier Arg1:T22 Arg2:T23	
T24	Temporal 800 814	within 30 days
T25	Qualifier 833 839	active
T26	Condition 840 862	gastrointestinal ulcer
R5	Has_qualifier Arg1:T26 Arg2:T25	
T27	Temporal 870 883	last 3 months
R6	Has_value Arg1:T14 Arg2:T15	
R7	Has_value Arg1:T16 Arg2:T17	
T28	Scope 697 799	intracranial hemorrhage or subdural hematoma, major surgery, parenchymal organ biopsy or severe trauma
*	OR T18 T19 T20 T21 T22
R8	Has_temporal Arg1:T28 Arg2:T24	
*	OR T14 T16 T28 T26
R9	Has_temporal Arg1:T26 Arg2:T27	
T30	Scope 628 883	platelets <50,000 / mm3 during screening, Hb <8.5 g / dL, history of intracranial hemorrhage or subdural hematoma, major surgery, parenchymal organ biopsy or severe trauma within 30 days before inclusion, active gastrointestinal ulcer in the last 3 months
R10	Subsumes Arg1:T12 Arg2:T30	
T29	Negation 486 489	not
T31	Mood 490 497	require
T32	Procedure 498 507	treatment
T33	Drug 513 520	aspirin
T34	Drug 534 552	antiplatelet agent
T35	Qualifier 528 533	other
R11	Has_qualifier Arg1:T34 Arg2:T35	
*	OR T33 T34
T36	Scope 513 552	aspirin or any other antiplatelet agent
R12	Has_scope Arg1:T32 Arg2:T36	
R13	Has_mood Arg1:T32 Arg2:T31	
R14	Has_negation Arg1:T31 Arg2:T29	
T37	Observation 572 582	history of
R15	Has_temporal Arg1:T11 Arg2:T37	
T38	Observation 886 896	History of
T39	Condition 897 903	Stroke
T40	Temporal 904 924	in the last 3 months
R16	Has_temporal Arg1:T39 Arg2:T40	
R17	Has_temporal Arg1:T39 Arg2:T38	
T41	Qualifier 927 935	Moderate
T42	Qualifier 939 945	severe
T43	Condition 946 961	liver affection
T44	Qualifier 962 990	associated with coagulopathy
T45	Condition 978 990	coagulopathy
R18	multi Arg1:T44 Arg2:T45	
R19	Has_qualifier Arg1:T43 Arg2:T44	
*	OR T42 T41
T46	Scope 927 945	Moderate or severe
R20	Has_scope Arg1:T43 Arg2:T46	
T47	Qualifier 992 998	Active
T48	Condition 999 1022	infectious endocarditis
R21	Has_qualifier Arg1:T48 Arg2:T47	
T49	Temporal 992 998	Active
R22	multi Arg1:T47 Arg2:T49	
T50	Qualifier 1024 1030	Active
T51	Temporal 1024 1030	Active
R23	multi Arg1:T50 Arg2:T51	
T52	Condition 1031 1036	tumor
T53	Procedure 1037 1044	treated
T54	Temporal 1045 1069	at the time of inclusion
R24	Has_temporal Arg1:T53 Arg2:T54	
R25	Has_qualifier Arg1:T52 Arg2:T50	
R26	AND Arg1:T53 Arg2:T52	
T55	Measurement 1086 1103	expected survival
T56	Value 1104 1122	less than one year
R27	Has_value Arg1:T55 Arg2:T56	
R28	AND Arg1:T52 Arg2:T55	
